Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DNA adduct and mutational profiles reveal a threshold of cellular defenses against <i>N</i>-nitrosodimethylamine administered to mice in drinking water.

NAR molecular medicine·2026
Same author

Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancer.

NAR cancer·2026
Same author

Early life exposure to N-nitrosamine drives genotoxicity, mutagenesis, and tumorigenesis in DNA repair-deficient mice.

Nature communications·2026
Same author

Transferability and Reproducibility of the HepaRG CometChip Assay.

Environmental and molecular mutagenesis·2025
Same author

Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancer.

bioRxiv : the preprint server for biology·2025
Same author

Stock Inhalers in Chicago Public Schools: Using the RE-AIM Framework to Assess Impact.

Pediatrics·2025

Related Experiment Video

Updated: Aug 27, 2025

CometChip: A High-throughput 96-Well Platform for Measuring DNA Damage in Microarrayed Human Cells
10:59

CometChip: A High-throughput 96-Well Platform for Measuring DNA Damage in Microarrayed Human Cells

Published on: October 18, 2014

17.5K

Using the HepaCometChip Assay for Broad-Spectrum DNA Damage Analysis.

Norah A Owiti1, Simran Kaushal1, Lincoln Martin2

  • 1Department of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts.

Current Protocols
|September 27, 2022
PubMed
Summary

The HepaCometChip assay offers a faster, more sensitive in vitro method for detecting DNA damage in liver cells, potentially replacing animal testing for genotoxicity. This advanced comet assay captures metabolic activation and detects bulky DNA adducts.

Keywords:
CometChipDNA damageHepaCometChipbulky lesionscomet assaygenotoxicitymetabolic activationsingle-strand breaks

More Related Videos

A High-Throughput Comet Assay Approach for Assessing Cellular DNA Damage
07:57

A High-Throughput Comet Assay Approach for Assessing Cellular DNA Damage

Published on: May 10, 2022

5.1K
A Simple, Rapid, and Quantitative Assay to Measure Repair of DNA-protein Crosslinks on Plasmids Transfected into Mammalian Cells
11:58

A Simple, Rapid, and Quantitative Assay to Measure Repair of DNA-protein Crosslinks on Plasmids Transfected into Mammalian Cells

Published on: March 5, 2018

8.3K

Related Experiment Videos

Last Updated: Aug 27, 2025

CometChip: A High-throughput 96-Well Platform for Measuring DNA Damage in Microarrayed Human Cells
10:59

CometChip: A High-throughput 96-Well Platform for Measuring DNA Damage in Microarrayed Human Cells

Published on: October 18, 2014

17.5K
A High-Throughput Comet Assay Approach for Assessing Cellular DNA Damage
07:57

A High-Throughput Comet Assay Approach for Assessing Cellular DNA Damage

Published on: May 10, 2022

5.1K
A Simple, Rapid, and Quantitative Assay to Measure Repair of DNA-protein Crosslinks on Plasmids Transfected into Mammalian Cells
11:58

A Simple, Rapid, and Quantitative Assay to Measure Repair of DNA-protein Crosslinks on Plasmids Transfected into Mammalian Cells

Published on: March 5, 2018

8.3K

Area of Science:

  • Hepatotoxicity and Genotoxicity Testing
  • In Vitro Toxicology Models
  • Biotechnology and Assay Development

Background:

  • The liver's vulnerability to DNA damaging agents necessitates robust genotoxicity testing.
  • Current in vivo preclinical testing for liver genotoxicity is animal-intensive.
  • Existing alkaline comet assays have limitations including speed, sensitivity to bulky adducts, and metabolic capacity.

Purpose of the Study:

  • To develop a high-throughput, metabolically competent in vitro assay for detecting genotoxicity in liver cells.
  • To improve upon the limitations of the traditional alkaline comet assay for preclinical drug safety evaluation.
  • To provide an alternative to animal testing for assessing DNA damage induced by xenobiotics.

Main Methods:

  • Development of the HepaCometChip assay, integrating metabolically competent HepaRG cells into a CometChip platform.
  • Utilization of repair trapping to enhance sensitivity for bulky DNA adducts by converting them to detectable single-strand breaks.
  • Establishment of protocols for HepaRG cell culturing, dosing, and CometChip assay performance.

Main Results:

  • The HepaCometChip assay demonstrates higher throughput compared to traditional methods.
  • The assay effectively captures metabolic activation of xenobiotics within the cells.
  • Increased sensitivity for detecting bulky DNA lesions is achieved through the repair trapping mechanism.

Conclusions:

  • The HepaCometChip assay presents a promising in vitro alternative for genotoxicity testing, particularly for liver cells.
  • This assay addresses key limitations of conventional methods, including speed and sensitivity to bulky adducts.
  • The HepaCometChip assay contributes to the reduction and replacement of animal use in preclinical safety assessments.